| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |